{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"","title":"Babbage: Another dose of good news","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/62e286a934d4d9fe5e874247/62e286c1bd17c20012ef40a3.jpg?height=200","description":"

Following promising results from Pfizer and Moderna, why is a third vaccine, from Oxford University and AstraZeneca, so important in the fight against covid-19? Host Kenneth Cukier and The Economist’s health policy editor Natasha Loder investigate the different approaches to this immense challenge. And Nicholas Christakis, a doctor and network scientist at Yale University, explains how despite a vaccine the pandemic could change humanity for good.


Please subscribe to The Economist for full access to print, digital and audio editions:

www.economist.com/podcastoffer


","author_name":"The Economist"}